WallStreetZenWallStreetZen

NASDAQ: CHEK
Check Cap Ltd Stock

Overview
ForecastEarningsDividendOwnership
$2.26+0.08 (+3.67%)
Updated Apr 18, 2024
CHEK Price
$2.26
Fair Value Price
$0.55
Market Cap
$13.22M
52 Week Low
$1.27
52 Week High
$4.63
P/E
-0.75x
P/B
0.48x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$17.62M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.06
Operating Cash Flow
-$18M
Beta
0.56
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CHEK Overview

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Zen Score

–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CHEK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CHEK ($2.26) is overvalued by 310.05% relative to our estimate of its Fair Value price of $0.55 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CHEK ($2.26) is not significantly undervalued (310.05%) relative to our estimate of its Fair Value price of $0.55 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CHEK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CHEK due diligence checks available for Premium users.

Be the first to know about important CHEK news, forecast changes, insider trades & much more!

CHEK News

Valuation

CHEK fair value

Fair Value of CHEK stock based on Discounted Cash Flow (DCF)
Price
$2.26
Fair Value
$0.55
Overvalued by
310.05%
CHEK ($2.26) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CHEK ($2.26) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CHEK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CHEK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.75x
Industry
36.3x
Market
41.33x

CHEK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.48x
Industry
4.01x
CHEK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CHEK's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.6M
Profit Margin
0%
CHEK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$29.0M
Liabilities
$1.6M
Debt to equity
0.06
CHEK's short-term assets ($28.77M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CHEK's short-term assets ($28.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CHEK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CHEK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.6M
Investing
$4.5M
Financing
$0.0
CHEK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CHEK vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
CHEK$13.22M+3.67%-0.75x0.48x
STRR$13.49M-3.30%0.53x0.21x
CNTG$12.72M-3.96%-0.29x-0.77x
TRIB$14.41M+2.17%N/A-0.60x
PMD$14.70M+0.79%-3.56x2.20x
View Top Diagnostic & Research Stocks

Check Cap Stock FAQ

What is Check Cap's quote symbol?

(NASDAQ: CHEK) Check Cap trades on the NASDAQ under the ticker symbol CHEK. Check Cap stock quotes can also be displayed as NASDAQ: CHEK.

If you're new to stock investing, here's how to buy Check Cap stock.

What is the 52 week high and low for Check Cap (NASDAQ: CHEK)?

(NASDAQ: CHEK) Check Cap's 52-week high was $4.63, and its 52-week low was $1.27. It is currently -51.14% from its 52-week high and 77.95% from its 52-week low.

How much is Check Cap stock worth today?

(NASDAQ: CHEK) Check Cap currently has 5,849,756 outstanding shares. With Check Cap stock trading at $2.26 per share, the total value of Check Cap stock (market capitalization) is $13.22M.

Check Cap stock was originally listed at a price of $1,459.20 in Mar 4, 2015. If you had invested in Check Cap stock at $1,459.20, your return over the last 9 years would have been -99.85%, for an annualized return of -51.27% (not including any dividends or dividend reinvestments).

How much is Check Cap's stock price per share?

(NASDAQ: CHEK) Check Cap stock price per share is $2.26 today (as of Apr 18, 2024).

What is Check Cap's Market Cap?

(NASDAQ: CHEK) Check Cap's market cap is $13.22M, as of Apr 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Check Cap's market cap is calculated by multiplying CHEK's current stock price of $2.26 by CHEK's total outstanding shares of 5,849,756.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.